15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysisResearch in context

15 years of patient-reported outcomes in clinical trials leading to GU cancer drug approvals: a systematic review on the quality of data reporting and analysisResearch in context

Summary: Background: Standardized, high-quality PRO data reporting is crucial for patient centered care in the field of oncology, especially in clinical trials that establish standard of care. This study evaluated PRO endpoint design, conduct and reporting methods in FDA approved drugs for GU malig...

Full description

Bibliographic Details
Main Authors: Mahati Paravathaneni, Houssein Safa, Vidhu Joshi, Monica K. Tamil, Jacob J. Adashek, Filip Ionescu, Savan Shah, Juskaran S. Chadha, Scott Gilbert, Brandon Manley, Adele Semaan, Heather S.L. Jim, Denise Kalos, Youngchul Kim, Philippe E. Spiess, Jad Chahoud
Format: Article
Language:English
Published: Elsevier 2024-02-01
Series:EClinicalMedicine
Subjects:
Patient reported outcomes
Renal cell cancer
Prostate cancer
Urothelial cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537023005904

Internet

http://www.sciencedirect.com/science/article/pii/S2589537023005904

Similar Items